Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1934 1
1936 1
1939 1
1940 1
1943 1
1949 1
1950 1
1951 3
1952 2
1953 2
1954 2
1955 1
1956 1
1966 1
1967 1
1968 1
1970 2
1973 2
1974 1
1976 1
1977 2
1989 1
1997 2
1999 1
2008 1
2010 1
2012 2
2013 1
2015 1
2016 1
2020 2
2021 3
2022 2
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Real-world use of nirmatrelvir-ritonavir in COVID-19 outpatients during BQ.1, BQ.1.1., and XBB.1.5 predominant omicron variants in three U.S. health systems: a retrospective cohort study.
Aggarwal NR, Beaty LE, Bennett TD, Fish LE, Jacobs JR, Mayer DA, Molina KC, Peers JL, Richardson DB, Russell S, Varela A, Webb BJ, Wynia MK, Xiao M, Carlson NE, Ginde AA. Aggarwal NR, et al. Among authors: peers jl. Lancet Reg Health Am. 2024 Feb 9;31:100693. doi: 10.1016/j.lana.2024.100693. eCollection 2024 Mar. Lancet Reg Health Am. 2024. PMID: 38500962 Free PMC article.
Effectiveness of subcutaneous monoclonal antibody treatment in emergency department outpatients with COVID-19.
Wendel SK, Wogu AF, Carlson NE, Beaty L, Bennett TD, Bookman K, Mayer DA, Michael SM, Molina KC, Peers JL, Russell S, Zane RD, Ginde AA. Wendel SK, et al. Among authors: peers jl. J Am Coll Emerg Physicians Open. 2024 Feb 21;5(1):e13116. doi: 10.1002/emp2.13116. eCollection 2024 Feb. J Am Coll Emerg Physicians Open. 2024. PMID: 38384380 Free PMC article.
Real-world use of nirmatrelvir-ritonavir in outpatients with COVID-19 during the era of omicron variants including BA.4 and BA.5 in Colorado, USA: a retrospective cohort study.
Aggarwal NR, Molina KC, Beaty LE, Bennett TD, Carlson NE, Mayer DA, Peers JL, Russell S, Wynia MK, Ginde AA. Aggarwal NR, et al. Among authors: peers jl. Lancet Infect Dis. 2023 Jun;23(6):696-705. doi: 10.1016/S1473-3099(23)00011-7. Epub 2023 Feb 10. Lancet Infect Dis. 2023. PMID: 36780912 Free PMC article.
Association between treatment failure and hospitalization after receipt of neutralizing monoclonal antibody treatment for COVID-19 outpatients.
Douin DJ, Wogu AF, Beaty LE, Carlson NE, Bennett TD, Aggarwal NR, Mayer DA, Ong TC, Russell S, Steele J, Peers JL, Molina KC, Wynia MK, Ginde AA. Douin DJ, et al. Among authors: peers jl. BMC Infect Dis. 2022 Nov 7;22(1):818. doi: 10.1186/s12879-022-07819-z. BMC Infect Dis. 2022. PMID: 36344927 Free PMC article.
Change in effectiveness of sotrovimab for preventing hospitalization and mortality for at-risk COVID-19 outpatients during an Omicron BA.1 and BA.1.1-predominant phase.
Aggarwal NR, Beaty LE, Bennett TD, Carlson NE, Mayer DA, Molina KC, Peers JL, Russell S, Wynia MK, Ginde AA. Aggarwal NR, et al. Among authors: peers jl. Int J Infect Dis. 2023 Mar;128:310-317. doi: 10.1016/j.ijid.2022.10.002. Epub 2022 Oct 10. Int J Infect Dis. 2023. PMID: 36229005 Free PMC article.
Early Convalescent Plasma for High-Risk Outpatients with Covid-19.
Korley FK, Durkalski-Mauldin V, Yeatts SD, Schulman K, Davenport RD, Dumont LJ, El Kassar N, Foster LD, Hah JM, Jaiswal S, Kaplan A, Lowell E, McDyer JF, Quinn J, Triulzi DJ, Van Huysen C, Stevenson VLW, Yadav K, Jones CW, Kea B, Burnett A, Reynolds JC, Greineder CF, Haas NL, Beiser DG, Silbergleit R, Barsan W, Callaway CW; SIREN-C3PO Investigators. Korley FK, et al. N Engl J Med. 2021 Nov 18;385(21):1951-1960. doi: 10.1056/NEJMoa2103784. Epub 2021 Aug 18. N Engl J Med. 2021. PMID: 34407339 Free PMC article. Clinical Trial.
Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years - United States, January-March 2021.
Tenforde MW, Olson SM, Self WH, Talbot HK, Lindsell CJ, Steingrub JS, Shapiro NI, Ginde AA, Douin DJ, Prekker ME, Brown SM, Peltan ID, Gong MN, Mohamed A, Khan A, Exline MC, Files DC, Gibbs KW, Stubblefield WB, Casey JD, Rice TW, Grijalva CG, Hager DN, Shehu A, Qadir N, Chang SY, Wilson JG, Gaglani M, Murthy K, Calhoun N, Monto AS, Martin ET, Malani A, Zimmerman RK, Silveira FP, Middleton DB, Zhu Y, Wyatt D, Stephenson M, Baughman A, Womack KN, Hart KW, Kobayashi M, Verani JR, Patel MM; IVY Network; HAIVEN Investigators. Tenforde MW, et al. MMWR Morb Mortal Wkly Rep. 2021 May 7;70(18):674-679. doi: 10.15585/mmwr.mm7018e1. MMWR Morb Mortal Wkly Rep. 2021. PMID: 33956782 Free PMC article.
51 results